Alzheimer’s Biomarkers

Biomarkers for Alzheimer’s disease are measurable indicators of changes in the brain that signal the presence or risk of the disease. Common biomarkers include beta-amyloid plaques, tau tangles, and signs of neurodegeneration or brain inflammation. These can be detected through brain scans, cerebrospinal fluid (CSF), or blood tests.

Latest news on Alzheimer’s biomarkers

 The three main types of Alzheimer’s biomarkers

Interactive learning guide: The Science of Alzheimer’s

Click on our interactive guide on the Science of Alzheimer’s to learn more.

 The role of blood tests in Alzheimer’s diagnosis

Blood Tests for Alzheimer’s

Blood tests for Alzheimer’s disease are an emerging diagnostic tool that aim to detect biological markers — or biomarkers — associated with the disease. These tests are not yet a stand-alone diagnostic method but are increasingly used to support diagnosis,
screen for risk, or rule out other causes of cognitive decline.

Specific biomarkers detected

  • Amyloid Beta 42/40 Ratio – A lower ratio in the blood is associated with amyloid buildup in the brain

  • Phosphorylated Tau (p-tau) – p-tau181, p-tau217, p-tau231 are among variants being studied. Elevated levels suggest tau pathology typical of Alzheimer’s

Interactive learning guide: Blood-based biomarkers for Alzheimer’s disease

Click on our interactive guide below to learn more.

Explore our lifestyle learning guides

Click on a topic below to view the guide.

Diet & Brain

Health

Sleep & Brain Health

Exercise & Brain Health

14 Ways to Prevent or Delay Dementia

Share your diagnosis story

Have you experienced symptoms that left you wondering if they were part of normal aging or something more serious? Did you reach out to a doctor for help shedding light on what was going on?
Tell us your about your journey to diagnosis. We’re looking for stories about how people have sought answers about their cognitive health, managed symptoms, and more.

Upload a file